BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24628233)

  • 1. Glycosylated antitumor ether lipids: activity and mechanism of action.
    Arthur G; Bittman R
    Anticancer Agents Med Chem; 2014 May; 14(4):592-606. PubMed ID: 24628233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An active endocytosis pathway is required for the cytotoxic effects of glycosylated antitumor ether lipids.
    Samadder P; Byun HS; Bittman R; Arthur G
    Anticancer Res; 2011 Nov; 31(11):3809-18. PubMed ID: 22110203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
    Samadder P; Xu Y; Schweizer F; Arthur G
    Eur J Med Chem; 2014 May; 78():225-35. PubMed ID: 24681987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR; Bittman R; Peters A; Mayhew E
    J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycosylated antitumor ether lipid kills cells via paraptosis-like cell death.
    Samadder P; Bittman R; Byun HS; Arthur G
    Biochem Cell Biol; 2009 Apr; 87(2):401-14. PubMed ID: 19370058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
    Ogunsina M; Samadder P; Idowu T; Arthur G; Schweizer F
    J Med Chem; 2017 Mar; 60(5):2142-2147. PubMed ID: 28177244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylated antitumor ether lipids are more effective against oncogene-transformed fibroblasts than alkyllysophospholipids.
    Samadder P; Byun HS; Bittman R; Arthur G
    Anticancer Res; 1998; 18(1A):465-70. PubMed ID: 9568121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of the antiproliferative effects of 1-O-hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D- glucopyranosyl)-sn-glycerol and 1-O-hexadecyl-2-O-methyl-3-0- (2'-amino-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol on epithelial cancer cell growth.
    Erukulla RK; Zhou X; Samadder P; Arthur G; Bittman R
    J Med Chem; 1996 Mar; 39(7):1545-8. PubMed ID: 8691486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL)- chlorambucil-hybrids.
    Idowu T; Samadder P; Arthur G; Schweizer F
    Chem Phys Lipids; 2016 Jan; 194():139-48. PubMed ID: 26188768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells.
    Idowu T; Samadder P; Arthur G; Schweizer F
    J Med Chem; 2017 Dec; 60(23):9724-9738. PubMed ID: 29043812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses of L-Rhamnose-Linked Amino Glycerolipids and Their Cytotoxic Activities against Human Cancer Cells.
    Ogunsina M; Samadder P; Idowu T; Nachtigal M; Schweizer F; Arthur G
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32012953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells.
    Moraya AI; Ali JL; Samadder P; Liang L; Morrison LC; Werbowetski-Ogilvie TE; Ogunsina M; Schweizer F; Arthur G; Nachtigal MW
    J Exp Clin Cancer Res; 2017 May; 36(1):67. PubMed ID: 28499442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.
    Salari H; Dryden P; Davenport R; Howard S; Jones K; Bittman R
    Biochim Biophys Acta; 1992 Feb; 1134(1):81-8. PubMed ID: 1543759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells.
    Gajate C; Mollinedo F
    Curr Drug Metab; 2002 Oct; 3(5):491-525. PubMed ID: 12369895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
    Civoli F; Daniel LW
    Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
    Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
    J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
    Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
    Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
    Jaffrès PA; Gajate C; Bouchet AM; Couthon-Gourvès H; Chantôme A; Potier-Cartereau M; Besson P; Bougnoux P; Mollinedo F; Vandier C
    Pharmacol Ther; 2016 Sep; 165():114-31. PubMed ID: 27288726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
    Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.